動物用静脈内溶液市場-世界の産業規模、シェア、動向、機会、予測、製品別、適応症別、動物タイプ別、最終用途別、地域別、競合別、2020年～2030年

世界の動物用静脈内溶液市場は、2024年には13億5,000万米ドルとなり、予測期間中のCAGRは6.57%で、2030年までに新たな高みに達し、大幅に拡大すると予測されています。

この成長は、輸液が治療プロトコルに不可欠である人間のヘルスケアの動向を反映した、動物医療の進歩を反映しています。動物用静脈内溶液は、さまざまな動物タイプにおける水分補給、薬物投与、重要な治療に不可欠です。世界のペット飼育の増加、動物医療への期待の高まり、2024年に北米で報告された625万匹のペット保険加入など、保険加入ペット数の増加がこの需要急増の主な要因となっています。これらの溶液は、日常的な状況でも緊急の状況でも使用され、獣医学的環境における回復と治療効果をサポートします。人と動物の絆が深まり、ペットのケアが高度化するにつれて、信頼性が高く効果的な点滴療法のニーズは高まり続け、世界の市場拡大の原動力となっています。

主要な市場促進要因

ペット飼育率の上昇と人間化が世界の動物用点滴ソリューション市場を牽引

主要な市場課題

限られた研究と製剤の多様性が市場拡大の大きな障害に

主要な市場動向

技術の進歩

目次

第1章 製品概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の動物用静脈内（IV）溶液市場の展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 製品別（等張晶質液、合成コロイド、血液製剤、ブドウ糖液、経腸栄養）
  • 適応症別（糖尿病性ケトアシドーシス、膵炎、炭疽病、慢性腎臓病、その他）
  • 動物タイプ別（コンパニオンアニマル、プロダクションアニマル）
  • 用途別（動物病院、研究機関、その他）
  • 地域別
  • 企業別（市場上位5社のシェア）
• 市場マップ
  • 製品別
  • 適応症別
  • 動物タイプ別
  • 最終用途別
  • 地域別

第6章 北米の動物用静脈内（IV）溶液市場の展望

• 市場規模・予測
• 市場シェア・予測

第7章 欧州動物用静脈内（IV）溶液市場の展望

• 市場規模・予測
• 市場シェア・予測

第8章 アジア太平洋の動物用静脈内（IV）溶液市場の展望

• 市場規模・予測
• 市場シェア・予測

第9章 南米の動物用静脈内（IV）溶液市場の展望

• 市場規模・予測
• 市場シェア・予測

第10章 中東・アフリカの動物用静脈内（IV）溶液市場の展望

• 市場規模・予測
• 市場シェア・予測

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 最近の動向
• 合併と買収
• 製品上市

第13章 競合情勢

• Merck & Co., Inc.
• Dechra Veterinary Products
• Sypharma
• Animalcare
• B. Braun SE
• Woods Consulting, LLC
• Baxter International
• Fresenius Kabi

第14章 戦略的提言

第15章 調査会社について・免責事項

The Global Veterinary Intravenous (IV) Solutions Market was valued at USD 1.35 billion in 2024 and is projected to expand significantly, reaching new heights by 2030 with a CAGR of 6.57% during the forecast period. This growth reflects advancements in veterinary medicine, mirroring trends in human healthcare, where IV solutions are integral to treatment protocols. Veterinary IV solutions are crucial for hydration, medication delivery, and critical care across a variety of animal species. Increasing global pet ownership, heightened expectations for animal care, and the growing number of insured pets-such as the 6.25 million pets reported insured in North America in 2024-are major contributors to this surge in demand. These solutions are used in both routine and emergency situations, supporting recovery and treatment efficacy in veterinary settings. As the human-animal bond deepens and pet care becomes more sophisticated, the need for reliable, effective IV therapies continues to grow, driving market expansion worldwide.

Key Market Drivers

Rising Pet Ownership and Humanization is Driving the Global Veterinary Intravenous (IV) Solutions Market

The rapid increase in global pet ownership and the growing trend of treating pets as family members are significantly boosting demand for veterinary healthcare services, including IV solutions. In the U.S., approximately 67% of households own a pet, a trend echoed in many other regions. This humanization of pets has transformed the way owners approach healthcare, prompting greater interest in advanced medical treatments similar to those used for humans. Veterinary IV solutions, vital for administering fluids, medications, and nutrients during critical care, are increasingly in demand as pet owners seek comprehensive and high-quality medical support. The surge in pet insurance coverage also supports this growth by making advanced veterinary treatments more financially accessible, encouraging more pet owners to opt for intensive interventions that include IV therapy.

Key Market Challenges

Limited Research and Formulation Variety Poses a Significant Obstacle To Market Expansion

A significant challenge facing the veterinary IV solutions market is the limited research and formulation diversity tailored to various animal species. Unlike human IV solutions, which benefit from extensive R&D and specificity, veterinary formulations often lack the same level of customization. This is particularly problematic for exotic and less common species that have unique physiological needs not addressed by standard formulations. The limited number of species-specific products restricts veterinarians' ability to deliver optimal care, which can impact treatment outcomes. This gap in product variety hinders market expansion and highlights the need for increased investment in research to develop a broader range of targeted IV solutions across diverse animal categories.

Key Market Trends

Technological Advancements

The integration of precision medicine and digital health technologies is reshaping the veterinary IV solutions market. Diagnostic innovations, such as genetic testing, allow for the formulation of personalized IV therapies, improving treatment effectiveness and patient outcomes. Telemedicine platforms and remote monitoring tools are also revolutionizing care delivery, enabling veterinarians to track patient vitals and modify IV regimens in real time without in-person visits. Moreover, smart infusion pumps and automated delivery systems enhance accuracy and safety by precisely controlling fluid and medication administration. These systems can adapt dosages dynamically based on live data. The adoption of digital health records and analytics further supports data-driven treatment decisions, improving care outcomes and contributing to the evolution of more targeted, efficient, and intelligent veterinary healthcare protocols.

Key Market Players

• Merck & Co., Inc.
• Dechra Veterinary Products
• Sypharma Pty Ltd.
• Animalcare group plc
• Braun SE
• Woods Consulting, LLC
• Baxter International
• Fresenius Kabi

Report Scope:

In this report, the Global Veterinary Intravenous (IV) Solutions Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Veterinary Intravenous (IV) Solutions Market, By Product:

• Isotonic crystalloids
• Synthetic colloids
• Blood products
• Dextrose solutions
• Parenteral nutrition

Veterinary Intravenous (IV) Solutions Market, By Indication:

• Diabetic Ketoacidosis
• Pancreatitis
• Anthrax
• Chronic Kidney Disease
• Others

Veterinary Intravenous (IV) Solutions Market, By Animal Type:

• Companion Animals
• Production Animals

Veterinary Intravenous (IV) Solutions Market, By End Use:

• Veterinary Hospitals
• Research Institutes
• Others

Veterinary Intravenous (IV) Solutions Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Veterinary Intravenous (IV) Solutions Market.

Available Customizations:

Global Veterinary Intravenous (IV) Solutions Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validations
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Veterinary Intravenous (IV) Solutions Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Isotonic crystalloids, Synthetic colloids, Blood products, Dextrose solutions, Parenteral nutrition)
  • 5.2.2. By Indication (Diabetic Ketoacidosis, Pancreatitis, Anthrax, Chronic Kidney Disease, Others)
  • 5.2.3. By Animal type (Companion Animals, Production Animals)
  • 5.2.4. By End Use (Veterinary Hospitals, Research Institutes, Others)
  • 5.2.5. By Region
  • 5.2.6. By Company (Shares of Top 5 Market Players)
• 5.3. Market Map
  • 5.3.1. By Product
  • 5.3.2. By Indication
  • 5.3.3. By Animal type
  • 5.3.4. By End Use
  • 5.3.5. By Region

6. North America Veterinary Intravenous (IV) Solutions Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Indication
  • 6.2.3. By Animal type
  • 6.2.4. By End Use
  • 6.2.5. By Country
    • 6.2.5.1. United States Veterinary Intravenous (IV) Solutions Market Outlook
      • 6.2.5.1.1. Market Size & Forecast
      • 6.2.5.1.1.1. By Value
      • 6.2.5.1.2. Market Share & Forecast
      • 6.2.5.1.2.1. By Product
      • 6.2.5.1.2.2. By Indication
      • 6.2.5.1.2.3. By Animal type
      • 6.2.5.1.2.4. By End Use
    • 6.2.5.2. Canada Veterinary Intravenous (IV) Solutions Market Outlook
      • 6.2.5.2.1. Market Size & Forecast
      • 6.2.5.2.1.1. By Value
      • 6.2.5.2.2. Market Share & Forecast
      • 6.2.5.2.2.1. By Product
      • 6.2.5.2.2.2. By Indication
      • 6.2.5.2.2.3. By Animal type
      • 6.2.5.2.2.4. By End Use
    • 6.2.5.3. Mexico Veterinary Intravenous (IV) Solutions Market Outlook
      • 6.2.5.3.1. Market Size & Forecast
      • 6.2.5.3.1.1. By Value
      • 6.2.5.3.2. Market Share & Forecast
      • 6.2.5.3.2.1. By Product
      • 6.2.5.3.2.2. By Indication
      • 6.2.5.3.2.3. By Animal type
      • 6.2.5.3.2.4. By End Use

7. Europe Veterinary Intravenous (IV) Solutions Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Indication
  • 7.2.3. By Animal type
  • 7.2.4. By End Use
  • 7.2.5. By Country
    • 7.2.5.1. France Veterinary Intravenous (IV) Solutions Market Outlook
      • 7.2.5.1.1. Market Size & Forecast
      • 7.2.5.1.1.1. By Value
      • 7.2.5.1.2. Market Share & Forecast
      • 7.2.5.1.2.1. By Product
      • 7.2.5.1.2.2. By Indication
      • 7.2.5.1.2.3. By Animal type
      • 7.2.5.1.2.4. By End Use
    • 7.2.5.2. Germany Veterinary Intravenous (IV) Solutions Market Outlook
      • 7.2.5.2.1. Market Size & Forecast
      • 7.2.5.2.1.1. By Value
      • 7.2.5.2.2. Market Share & Forecast
      • 7.2.5.2.2.1. By Product
      • 7.2.5.2.2.2. By Indication
      • 7.2.5.2.2.3. By Animal type
      • 7.2.5.2.2.4. By End Use
    • 7.2.5.3. United Kingdom Veterinary Intravenous (IV) Solutions Market Outlook
      • 7.2.5.3.1. Market Size & Forecast
      • 7.2.5.3.1.1. By Value
      • 7.2.5.3.2. Market Share & Forecast
      • 7.2.5.3.2.1. By Product
      • 7.2.5.3.2.2. By Indication
      • 7.2.5.3.2.3. By Animal type
      • 7.2.5.3.2.4. By End Use
    • 7.2.5.4. Italy Veterinary Intravenous (IV) Solutions Market Outlook
      • 7.2.5.4.1. Market Size & Forecast
      • 7.2.5.4.1.1. By Value
      • 7.2.5.4.2. Market Share & Forecast
      • 7.2.5.4.2.1. By Product
      • 7.2.5.4.2.2. By Indication
      • 7.2.5.4.2.3. By Animal type
      • 7.2.5.4.2.4. By End Use
    • 7.2.5.5. Spain Veterinary Intravenous (IV) Solutions Market Outlook
      • 7.2.5.5.1. Market Size & Forecast
      • 7.2.5.5.1.1. By Value
      • 7.2.5.5.2. Market Share & Forecast
      • 7.2.5.5.2.1. By Product
      • 7.2.5.5.2.2. By Indication
      • 7.2.5.5.2.3. By Animal type
      • 7.2.5.5.2.4. By End Use

8. Asia Pacific Veterinary Intravenous (IV) Solutions Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Indication
  • 8.2.3. By Animal type
  • 8.2.4. By End Use
  • 8.2.5. By Country
    • 8.2.5.1. China Veterinary Intravenous (IV) Solutions Market Outlook
      • 8.2.5.1.1. Market Size & Forecast
      • 8.2.5.1.1.1. By Value
      • 8.2.5.1.2. Market Share & Forecast
      • 8.2.5.1.2.1. By Product
      • 8.2.5.1.2.2. By Indication
      • 8.2.5.1.2.3. By Animal type
      • 8.2.5.1.2.4. By End Use
    • 8.2.5.2. India Veterinary Intravenous (IV) Solutions Market Outlook
      • 8.2.5.2.1. Market Size & Forecast
      • 8.2.5.2.1.1. By Value
      • 8.2.5.2.2. Market Share & Forecast
      • 8.2.5.2.2.1. By Product
      • 8.2.5.2.2.2. By Indication
      • 8.2.5.2.2.3. By Animal type
      • 8.2.5.2.2.4. By End Use
    • 8.2.5.3. South Korea Veterinary Intravenous (IV) Solutions Market Outlook
      • 8.2.5.3.1. Market Size & Forecast
      • 8.2.5.3.1.1. By Value
      • 8.2.5.3.2. Market Share & Forecast
      • 8.2.5.3.2.1. By Product
      • 8.2.5.3.2.2. By Indication
      • 8.2.5.3.2.3. By Animal type
      • 8.2.5.3.2.4. By End Use
    • 8.2.5.4. Japan Veterinary Intravenous (IV) Solutions Market Outlook
      • 8.2.5.4.1. Market Size & Forecast
      • 8.2.5.4.1.1. By Value
      • 8.2.5.4.2. Market Share & Forecast
      • 8.2.5.4.2.1. By Product
      • 8.2.5.4.2.2. By Indication
      • 8.2.5.4.2.3. By Animal type
      • 8.2.5.4.2.4. By End Use
    • 8.2.5.5. Australia Veterinary Intravenous (IV) Solutions Market Outlook
      • 8.2.5.5.1. Market Size & Forecast
      • 8.2.5.5.1.1. By Value
      • 8.2.5.5.2. Market Share & Forecast
      • 8.2.5.5.2.1. By Product
      • 8.2.5.5.2.2. By Indication
      • 8.2.5.5.2.3. By Animal type
      • 8.2.5.5.2.4. By End Use

9. South America Veterinary Intravenous (IV) Solutions Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Indication
  • 9.2.3. By Animal type
  • 9.2.4. By End Use
  • 9.2.5. By Country
    • 9.2.5.1. Brazil Veterinary Intravenous (IV) Solutions Market Outlook
      • 9.2.5.1.1. Market Size & Forecast
      • 9.2.5.1.1.1. By Value
      • 9.2.5.1.2. Market Share & Forecast
      • 9.2.5.1.2.1. By Product
      • 9.2.5.1.2.2. By Indication
      • 9.2.5.1.2.3. By Animal type
      • 9.2.5.1.2.4. By End Use
    • 9.2.5.2. Argentina Veterinary Intravenous (IV) Solutions Market Outlook
      • 9.2.5.2.1. Market Size & Forecast
      • 9.2.5.2.1.1. By Value
      • 9.2.5.2.2. Market Share & Forecast
      • 9.2.5.2.2.1. By Product
      • 9.2.5.2.2.2. By Indication
      • 9.2.5.2.2.3. By Animal type
      • 9.2.5.2.2.4. By End Use
    • 9.2.5.3. Colombia Veterinary Intravenous (IV) Solutions Market Outlook
      • 9.2.5.3.1. Market Size & Forecast
      • 9.2.5.3.1.1. By Value
      • 9.2.5.3.2. Market Share & Forecast
      • 9.2.5.3.2.1. By Product
      • 9.2.5.3.2.2. By Indication
      • 9.2.5.3.2.3. By Animal type
      • 9.2.5.3.2.4. By End Use

10. Middle East & Africa Veterinary Intravenous (IV) Solutions Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Indication
  • 10.2.3. By Animal type
  • 10.2.4. By End Use
  • 10.2.5. By Country
    • 10.2.5.1. South Africa Veterinary Intravenous (IV) Solutions Market Outlook
      • 10.2.5.1.1. Market Size & Forecast
      • 10.2.5.1.1.1. By Value
      • 10.2.5.1.2. Market Share & Forecast
      • 10.2.5.1.2.1. By Product
      • 10.2.5.1.2.2. By Indication
      • 10.2.5.1.2.3. By Animal type
      • 10.2.5.1.2.4. By End Use
    • 10.2.5.2. Saudi Arabia Veterinary Intravenous (IV) Solutions Market Outlook
      • 10.2.5.2.1. Market Size & Forecast
      • 10.2.5.2.1.1. By Value
      • 10.2.5.2.2. Market Share & Forecast
      • 10.2.5.2.2.1. By Product
      • 10.2.5.2.2.2. By Indication
      • 10.2.5.2.2.3. By Animal type
      • 10.2.5.2.2.4. By End Use
    • 10.2.5.3. UAE Veterinary Intravenous (IV) Solutions Market Outlook
      • 10.2.5.3.1. Market Size & Forecast
      • 10.2.5.3.1.1. By Value
      • 10.2.5.3.2. Market Share & Forecast
      • 10.2.5.3.2.1. By Product
      • 10.2.5.3.2.2. By Indication
      • 10.2.5.3.2.3. By Animal type
      • 10.2.5.3.2.4. By End Use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Competitive Landscape

• 13.1. Merck & Co., Inc.
  • 13.1.1. Business Overview
  • 13.1.2. Company Snapshot
  • 13.1.3. Products & Service
  • 13.1.4. Financials (As Reported)
  • 13.1.5. Recent Developments
  • 13.1.6. Key Personnel Details
  • 13.1.7. SWOT Analysis
• 13.2. Dechra Veterinary Products
• 13.3. Sypharma
• 13.4. Animalcare
• 13.5. B. Braun SE
• 13.6. Woods Consulting, LLC
• 13.7. Baxter International
• 13.8. Fresenius Kabi

14. Strategic Recommendations

15. About us & Disclaimer